---
title: "Tandem Diabetes (TNDM.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TNDM.US/norm.md"
symbol: "TNDM.US"
name: "Tandem Diabetes"
parent: "https://longbridge.com/en/quote/TNDM.US.md"
datetime: "2026-05-20T12:35:12.639Z"
locales:
  - [en](https://longbridge.com/en/quote/TNDM.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TNDM.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TNDM.US/norm.md)
---

# Tandem Diabetes (TNDM.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2982 | -0.0087 | -0.3129 | -0.7815 | -1.97 |
| ROE | -56.73% | -1.64% | -63.59% | -145.27% | -249.63% |
| Revenue | 247.22M | 290.38M | 249.25M | 240.68M | 234.42M |
| Net income | -20.39M | -589000.00 | -21.16M | -52.40M | -130.56M |
| Operating income | -17.43M | 8.29M | -20.06M | -31.86M | -34.49M |
| Gross margin | 55.33% | 57.67% | 53.88% | 52.29% | 50.51% |
| Net margin | -8.25% | -0.20% | -8.49% | -21.77% | -55.69% |
| Profit quality | -157.72% | 84.73% | -242.78% | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.15B | 881.11M | 874.65M | 875.74M | 922.14M |
| Leverage | 8.71 | 5.68 | 6.58 | 6.57 | 5.94 |
| BVPS | 1.93 | 2.27 | 1.96 | 1.97 | 2.33 |
| Turnover | 0.9901 | 1.10 | 1.10 | 1.10 | 1.06 |
| Cash & STI | 570.26M | 292.67M | 319.11M | 315.36M | 368.63M |
| Inv & Rec | 126.40M | 128.77M | 137.28M | 142.57M | 141.16M |
| LT assets | 178.99M | 179.75M | 176.28M | 175.95M | 180.24M |
| Net debt | 164.48M | 156.71M | 135.07M | 138.55M | 129.48M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 11.05M | 9.79M | 8.26M | -9.50M | -18.28M |
| Investing CF | -195.45M | -14.98M | 20.54M | 58.13M | 9.19M |
| Financing CF | 274.16M | 2.60M | -1.57M | -39.71M | -4.69M |
| Free CF | 21.13M | -52.51M | 10.03M | 4.32M | -3.48M |
| OCF coverage | 176.36% | 146.43% | 201.96% | -20.22% | -616.46% |
| Repaid & issued | 300.00M | - | - | - | - |
| CapEx | -6.27M | -6.68M | -4.09M | -6.21M | -2.96M |
